Company reported positive clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study Positive benefits were.
ASHBURN, Va., Nov. 03, 2023 Quoin Pharmaceuticals Ltd. , a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release.
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.